Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2026-02-20 @ 6:38 PM
Study NCT ID:
NCT05420493
Status:
UNKNOWN
Last Update Posted:
2024-01-05
First Post:
2022-06-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma
Sponsor:
Chongqing Precision Biotech Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-12
First Submit QC Date:
None
Study First Post Date:
2022-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-02
Last Update Post Date:
2024-01-05
Last Update Post Date Type:
ACTUAL